Use of a Flowable Haemostat Versus an Oxidised Regenerated Cellulose Agent in Primary Elective Cardiac Surgery: Economic Impact from a UK Healthcare Perspective
We investigated the economic impact of the use of a flowable haemostatic agent (Floseal) compared with non-flowable oxidised regenerated cellulose (ORC) agent in primary elective cardiac surgeryfrom the perspective of the UK National Health Service (NHS).